Drug intelligence / Profile preview

Dedu Honghua Qiwei San

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Dedu Honghua Qiwei San (德都红花七味散) is a traditional Chinese medicine (TCM) formula, specifically a multi-ingredient herbal preparation. It is indicated for conditions characterized by "liver stasis and blood heat," including liver pain, red eyes with jaundice, and yellow urine. Its primary traditional function is to "clear blood heat." The formula is composed of seven main ingredients: Honghua (Safflower), Mahuang (Ephedra), Shigao (Gypsum), Guan Mutong (Aristolochia manshuriensis stem), Zihua Diding (Viola yedoensis), Hezi (Terminalia chebula), and Lan Penhua (Scabiosa comosa). It is administered orally and is approved in China as a pharmaceutical product.

Brand names: Meng Wang
Other names: Dedou Honghua Qiwei San

Beyond the preview

Go deeper on Dedu Honghua Qiwei San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dedu Honghua Qiwei San.

Explore the full profile